Latigo Biotherapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-03-31 |
|---|---|---|
Revenue | $0 | $0 |
Net Income | -22,961 | -20,952 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -27,069 | -21,259 |
Cash | 42,177 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
Net Income | -109,167 | -61,183 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -97,693 | -51,027 |
Cash | 69,437 | 17,918 |